Revolixys (anivamersen/pegnivacogin) / AbbVie 
Welcome,         Profile    Billing    Logout  
 10 Diseases   1 Trial   1 Trial   27 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Revolixys (anivamersen/pegnivacogin) / AbbVie
2009-012803-24: A RANDOMIZED, PARTIALLY-BLINDED, MULTI-CENTER, ACTIVE-CONTROLLED, DOSE RANGING STUDY ASSESSING THE SAFETY, EFFICACY, AND PHARMACODYNAMICS OF THE REG1 ANTICOAGULATION SYSTEM COMPARED TO UNFRACTIONATED HEPARIN OR LOW MOLECULAR HEPARIN IN SUBJECTS WITH ACUTE CORONARY SYNDROME

 
2
150
Europe
RB006, RB007, REG 1, Heparin-ratium-5000-ratiopharm, Heparin-ratium-5000-ratiopharm
Regado Biosciences, Inc
Acute coronary syndrome
 
12/10

Download Options